1142 related articles for article (PubMed ID: 17918039)
21. Protective effects of antidepressants against chronic fatigue syndrome-induced behavioral changes and biochemical alterations.
Kumar A; Garg R
Fundam Clin Pharmacol; 2009 Feb; 23(1):89-95. PubMed ID: 19207541
[TBL] [Abstract][Full Text] [Related]
22. Activation of CREB by St. John's wort may diminish deletorious effects of aging on spatial memory.
Trofimiuk E; Holownia A; Braszko JJ
Arch Pharm Res; 2010 Mar; 33(3):469-77. PubMed ID: 20361314
[TBL] [Abstract][Full Text] [Related]
23. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort].
Röder C; Schaefer M; Leucht S
Fortschr Neurol Psychiatr; 2004 Jun; 72(6):330-43. PubMed ID: 15211398
[TBL] [Abstract][Full Text] [Related]
24. About the cover: St. John's wort.
J Soc Integr Oncol; 2006; 4(1):52-5. PubMed ID: 16737673
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of three species of Hypericum in an open field test.
Diana G; Capasso A; Quaranta E; De Feo V
Phytother Res; 2007 Mar; 21(3):215-9. PubMed ID: 17160972
[TBL] [Abstract][Full Text] [Related]
26. Preserved pharmacological activity of hepatocytes-treated extracts of valerian and St. John's wort.
Simmen U; Saladin C; Kaufmann P; Poddar M; Wallimann C; Schaffner W
Planta Med; 2005 Jul; 71(7):592-8. PubMed ID: 16041642
[TBL] [Abstract][Full Text] [Related]
27. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression.
Brattström A
Phytomedicine; 2009 Apr; 16(4):277-83. PubMed ID: 19299116
[TBL] [Abstract][Full Text] [Related]
28. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
Markowitz JS; DeVane CL
Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
[TBL] [Abstract][Full Text] [Related]
29. The effects of St. John's wort extract and amitriptyline on autonomic responses of blood vessels and sweat glands in healthy volunteers.
Siepmann M; Kirch W; Krause S; Joraschky P; Mueck-Weymann M
J Clin Psychopharmacol; 2004 Feb; 24(1):79-82. PubMed ID: 14709951
[TBL] [Abstract][Full Text] [Related]
30. The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver.
Dostalek M; Pistovcakova J; Jurica J; Sulcova A; Tomandl J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):253-7. PubMed ID: 22286810
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers.
Bauer S; Störmer E; Kerb R; Johne A; Brockmöller J; Roots I
Eur J Clin Pharmacol; 2002 Dec; 58(9):581-5. PubMed ID: 12483450
[TBL] [Abstract][Full Text] [Related]
32. The prototypic antidepressant drug, imipramine, but not Hypericum perforatum (St. John's Wort), reduces HPA-axis function in the rat.
Frost P; Bornstein S; Ehrhart-Bornstein M; O'Kirwan F; Hutson C; Heber D; Go V; Licinio J; Wong ML
Horm Metab Res; 2003 Oct; 35(10):602-6. PubMed ID: 14605995
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of St. John's wort extract (STW3-VI) during chronic restraint stress is mediated by the interrelationship of the immune, oxidative defense, and neuroendocrine system.
Grundmann O; Lv Y; Kelber O; Butterweck V
Neuropharmacology; 2010; 58(4-5):767-73. PubMed ID: 20036263
[TBL] [Abstract][Full Text] [Related]
34. [Mania during the use of a combination preparation with St. John's wort (Hypericum perforatum)].
Güzelcan Y; Scholte WF; Assies J; Becker HE
Ned Tijdschr Geneeskd; 2001 Oct; 145(40):1943-5. PubMed ID: 11675976
[TBL] [Abstract][Full Text] [Related]
35. [The administration of St. John's wort (Hypericum perforatum) in the treatment of depression].
Koszewska I
Psychiatr Pol; 2001; 35(2):199-210. PubMed ID: 11490885
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of antidepressant-like activity of novel water-soluble curcumin formulations and St. John's wort in behavioral paradigms of despair.
Kulkarni SK; Akula KK; Deshpande J
Pharmacology; 2012; 89(1-2):83-90. PubMed ID: 22343362
[TBL] [Abstract][Full Text] [Related]
37. Development of pregnancy in rats treated with Hypericum perforatum.
Borges LV; do Carmo Cancino JC; Peters VM; Las Casas L; de Oliveira Guerra M
Phytother Res; 2005 Oct; 19(10):885-7. PubMed ID: 16261520
[TBL] [Abstract][Full Text] [Related]
38. The antidepressant activity of Hypericum perforatum L. measured by two experimental methods on mice.
Bach-Rojecky L; Kalodjera Z; Samarzija I
Acta Pharm; 2004 Jun; 54(2):157-62. PubMed ID: 15274759
[TBL] [Abstract][Full Text] [Related]
39. A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's wort (Hypericum perforatum) herb extract (LI-160) as an aid to motivational/behavioural support in smoking cessation.
Barnes J; Barber N; Wheatley D; Williamson EM
Planta Med; 2006 Mar; 72(4):378-82. PubMed ID: 16557483
[TBL] [Abstract][Full Text] [Related]
40. Antidepressant action of St. John's Wort, Hypericum perforatum: a test of the circadian hypotheses.
Francis AJ
Phytomedicine; 2005 Mar; 12(3):167-72. PubMed ID: 15830836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
